These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 206196)
1. Comparison of biochemical and biological methods in the evaluation of new anthracycline drugs. Di Marco A; Zunino F; Casazza AM Antibiot Chemother (1971); 1978; 23():12-20. PubMed ID: 206196 [No Abstract] [Full Text] [Related]
2. Methods of screening antitumor antibiotics. Gauze GF; Shorin VA Natl Cancer Inst Monogr; 1977 Mar; (45):221-5. PubMed ID: 579249 [No Abstract] [Full Text] [Related]
3. Conformational preference for interaction of anthracycline antitumour antibiotics with chromatin. Tripathi PK; Ray SK; Neogy R; Panda CK Indian J Exp Biol; 1988 Jun; 26(6):453-6. PubMed ID: 3192286 [No Abstract] [Full Text] [Related]
4. [Comparative study of the antitumor action and toxicity of the antibiotic sibiromycin and its sulfur derivative]. Bazhanov VS; Shepelevtseva NG Antibiotiki; 1974 Aug; 19(8):714-7. PubMed ID: 4480345 [No Abstract] [Full Text] [Related]
5. Experimental evaluation of anthracycline analogs. Casazza AM Cancer Treat Rep; 1979 May; 63(5):835-44. PubMed ID: 455325 [TBL] [Abstract][Full Text] [Related]
6. [Experimental study of the aitumor activity of the antibiotic sibiromycin]. Shorin VA; Rossolimo OK Antibiotiki; 1970 Apr; 15(4):300-4. PubMed ID: 5536913 [No Abstract] [Full Text] [Related]
7. Bisantrene, biological and clinical effects. Coltman CA; Osborne CK Cancer Treat Rev; 1984 Dec; 11(4):285-8. PubMed ID: 6534510 [TBL] [Abstract][Full Text] [Related]
8. [Combined use of rubomycin and olivomycin in treatment of murine lymphosarcoma]. Shopin VA; Kriatova GN Antibiotiki; 1972 Apr; 17(4):325-9. PubMed ID: 5068419 [No Abstract] [Full Text] [Related]
11. Antitumor activity of cytochalasin D. Katagiri K; Matsuura S J Antibiot (Tokyo); 1971 Oct; 24(10):722-3. PubMed ID: 5158589 [No Abstract] [Full Text] [Related]
12. [Experimental study of the antitumor anthracycline antibiotic aclarubicin (aclacinomycin A)]. Egorov LV; Terent'eva TG; Rudneva NA; Egorenko GG; Ivanitskaia LP Antibiot Med Biotekhnol; 1985 Dec; 30(12):918-27. PubMed ID: 3866512 [TBL] [Abstract][Full Text] [Related]
13. Some observations on the action of actinomycin D, mitomycin C and jawaharene on transplanted mouse fibrosarcoma. Roy A; Chatterjee PC Indian J Cancer; 1974 Dec; 11(4):394-8. PubMed ID: 4468244 [No Abstract] [Full Text] [Related]
14. Comparison of antineoplastic activity of aminoethylaminoanthraquinones and anthracycline antibiotics. Cheng CC; Zbinden G; Zee-Cheng RK J Pharm Sci; 1979 Mar; 68(3):393-6. PubMed ID: 423142 [No Abstract] [Full Text] [Related]
15. [Antineoplastic activity of the anthracycline antibiotic violamycin BI in mice and rats using experimental metastases models (author's transl)]. Arnold W; Nowak C; Fleck WF; Strauss DG; Koch W Arch Geschwulstforsch; 1979; 49(5):386-90. PubMed ID: 518248 [TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerase II-mediated interaction of doxorubicin and daunorubicin congeners with DNA. Bodley A; Liu LF; Israel M; Seshadri R; Koseki Y; Giuliani FC; Kirschenbaum S; Silber R; Potmesil M Cancer Res; 1989 Nov; 49(21):5969-78. PubMed ID: 2551497 [TBL] [Abstract][Full Text] [Related]
17. [Effect of alkoxybenzylpyrimidylamidophosphoric acid diethyleneimides on DNA and RNA biosynthesis in the tissues of tumor-bearing rats and in sarcoma-45]. Stepanian GM; Chachoian AA; Garibian DV; Garibdzhanian BT Zh Eksp Klin Med; 1979; 19(3):66-71. PubMed ID: 494890 [No Abstract] [Full Text] [Related]
18. Biochemical parameters of growth inhibition of human leukemia cells by antitumor anthracycline agents. Schwartz HS; Kanter PM Cancer Treat Rep; 1979 May; 63(5):821-5. PubMed ID: 287555 [TBL] [Abstract][Full Text] [Related]
19. [Antineoplastic antibiotics from Streptomycetes]. Strauss D Arzneimittelforschung; 1970 Mar; 20(3):301-16. PubMed ID: 4315126 [No Abstract] [Full Text] [Related]
20. Biologic characterization and chemotherapeutic response of MS-2 tumor: a non-regressing mouse sarcoma derived from MSV-M-induced sarcoma. Giuliani F; Bellini O; Casazza AM; Formelli F; Savi G; Di Marco A Eur J Cancer (1965); 1978 May; 14(5):555-66. PubMed ID: 206445 [No Abstract] [Full Text] [Related] [Next] [New Search]